Cargando…
The Phosphodiesterase 4 Inhibitor Roflumilast Protects against Cigarette Smoke Extract-Induced Mitophagy-Dependent Cell Death in Epithelial Cells
BACKGROUND: Recent studies show that mitophagy, the autophagy-dependent turnover of mitochondria, mediates pulmonary epithelial cell death in response to cigarette smoke extract (CSE) exposure and contributes to the development of emphysema in vivo during chronic cigarette smoke (CS) exposure, altho...
Autores principales: | Kyung, Sun Young, Kim, Yu Jin, Son, Eun Suk, Jeong, Sung Hwan, Park, Jeong-Woong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874143/ https://www.ncbi.nlm.nih.gov/pubmed/29589382 http://dx.doi.org/10.4046/trd.2017.0115 |
Ejemplares similares
-
Effect of roflumilast on inflammatory cells in the lungs of cigarette smoke-exposed mice
por: Martorana, Piero A, et al.
Publicado: (2008) -
Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD
por: Giembycz, Mark A, et al.
Publicado: (2010) -
Roflumilast reverses CFTR-mediated ion transport dysfunction in cigarette smoke-exposed mice
por: Raju, S. Vamsee, et al.
Publicado: (2017) -
Roflumilast, a Novel Phosphodiesterase 4 Inhibitor, for COPD Patients with a History of Exacerbations
por: Field, Stephen K.
Publicado: (2011) -
Roflumilast, a phosphodiesterase-4 inhibitor, induces phagocytic activity in Greek COPD patients
por: Porpodis, Konstantinos, et al.
Publicado: (2015)